A comparative trial of cefazolin and moxalactam as prophylaxis for preventing infection after abdominal hysterectomy

Ruth E. Tuomala, Susan G. Fischer, Alvaro Muñoz, Paul F. Souney, Linda Steele, B. Frank Polk

Research output: Contribution to journalArticlepeer-review

Abstract

In a randomized, double-blind clinical trial, 208 women who underwent abdominal hysterectomy received either cefazolin (N = 108) or moxalactam (N = 100) as perioperative antimicrobial prophylaxis. There were no differences between the two groups in rates of serious infection, minor wound infection, standard febrile morbidity, duration of hospitalization, proportion receiving other postoperative antibiotics, or rates of rehospitalization. Women who received moxalactam had significantly more urinary tract infections, 87% of which were caused by the enterococcus. It is concluded that perioperative prophylaxis with thirdgeneration cephalosporins is not justified at this time.

Original languageEnglish (US)
Pages (from-to)372-376
Number of pages5
JournalObstetrics and gynecology
Volume66
Issue number3
StatePublished - Sep 1985

ASJC Scopus subject areas

  • Obstetrics and Gynecology

Fingerprint Dive into the research topics of 'A comparative trial of cefazolin and moxalactam as prophylaxis for preventing infection after abdominal hysterectomy'. Together they form a unique fingerprint.

Cite this